Ultragenyx Pharmaceutical Inc RARE Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.32B	1.62B	1.55B	1.38B	1.31B	1.24B	1.49B	1.31B
Total Current Assets	678.54M	1.01B	883.9M	766.34M	702.14M	599.19M	732.18M	595.97M
Cash and Equivalents	159.87M	391.65M	132.94M	85.77M	102.06M	72.58M	213.58M	112.25M
Total Non-Current Assets	642.09M	605.81M	921.27M	617.07M	609.17M	638.95M	1.05B	711.11M
Total Liabilities	642.55M	1.15B	1.19B	1.16B	1.18B	1.21B	1.22B	1.17B
Total Current Liabilities	220.64M	227.36M	261.21M	218.18M	244.38M	253.98M	280.44M	245.58M
Total Non-Current Liabilities	780.86M	1.78B	1.81B	944.74M	937.9M	952.45M	1.8B	921.24M
Common Equity	70k	70k	70k	71k	71k	72k	82k	83k
Retained Earnings	-2.38B	-2.63B	-2.78B	-2.94B	-3.1B	-3.26B	-3.39B	-3.56B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	540.63M	490.75M	719.56M	1.14B	1.76B	1.52B	1.55B	1.49B
Total Current Assets	401.7M	269.58M	522.37M	851.02M	1.3B	856.6M	883.9M	732.18M
Cash and Equivalents	161.12M	100.49M	113.43M	433.58M	713.53M	307.58M	132.94M	213.58M
Total Non-Current Assets	473.97M	383.45M	608.91M	653.76M	1.15B	922.56M	352.49M	275.41M
Total Liabilities	66.65M	107.3M	110.65M	481.73M	605.18M	599.84M	1.19B	1.22B
Total Current Liabilities	60.26M	71.01M	74.73M	103.3M	189.61M	181.37M	261.21M	280.44M
Total Non-Current Liabilities	6.39M	36.29M	35.93M	378.43M	751.94M	770.66M	1.81B	1.8B
Total Equity	473.97M	383.45M	608.91M	653.76M	1.15B	922.56M	352.49M	275.41M
Common Equity	41k	44k	51k	58k	67k	69k	70k	82k
Retained Earnings	-530.53M	-832.67M	-1.03B	-1.43B	-1.62B	-2.07B	-2.78B	-3.39B